AccuLine

AccuLine is dedicated to saving lives globally through innovative medical equipment manufacturing. AccuLine is actively developing CORA, a precise, non-invasive, and economical examination designed for the early detection of Coronary Artery Disease (CAD). This user-friendly exam involves a quick, four-minute measurement of vital signs, offering a superior alternative to traditional ergometry exams that are often inaccurate, time-consuming, and labor-intensive.

Located in Petah-Tikva, IL, AccuLine is committed to overcoming the limitations of current diagnostic tools by providing solutions that enhance accuracy and reduce invasiveness and cost. AccuLine's forward-thinking approach has garnered support from notable institutions, including grants from Google and the Israeli Innovation Authority, as well as investments from Mayo Clinic, eHealth Ventures, and Maccabi Healthcare Services.

AccuLine is poised to revolutionize cardiac diagnostics. We invite the manager of AccuLine to enhance your company's presence by creating a customized and exclusive company showcase and product listing on our platform, highlighting AccuLine's contributions to preventing heart attacks and advancing medical technology.